Purchase Order 36C24526P0222
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, received a $79,343.96 firm fixed-price purchase order from Veterans Integrated Service Network (VISN) 10 for Cepheid GeneXpert supplies, with a completion date of March 31, 2026. The award, announced on January 1, 2026, represents a standalone purchase order with no set-aside designation and reflects the Department of Veterans Affairs' continued reliance on Cepheid as a primary supplier of diagnostic...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a purchase order valued at $5.17 million by the Department of Veterans Affairs' Veterans Integrated Service Network 8 on October 1, 2022. This firm fixed-price contract, with no set-aside designation, is a modification to an existing agreement that adjusts clinical quantities based on updated workload estimates for microbiology testing services. The contract calls for an all-inclusive...
- Cepheid has been awarded a firm fixed-price delivery order valued at $40,704.72 by the Department of Veterans Affairs' Veterans Integrated Service Network 9 (VISN 9). The contract, with an ultimate completion date of May 31, 2025, is for molecular diagnostic solutions to be delivered and performed in Sunnyvale, California. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of advanced diagnostic systems and testing solutions to the...
- Cepheid Inc. was awarded a $306,000 firm fixed-price delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) on October 1, 2025, for the supply of Cepheid testing kits. The contract carries an ultimate completion date of March 31, 2026, with no set-aside designation. As a molecular diagnostics manufacturer headquartered in Sunnyvale, California, Cepheid supplies the federal healthcare system with advanced diagnostic solutions, particularly its...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a purchase order valued at $673,895.56 by Veterans Integrated Service Network 8 (VISN 8) for microbiology cost-per-test services. The contract, awarded on October 1, 2025, will be performed in Sunnyvale and extends through September 30, 2026. This firm fixed-price purchase order contains no set-aside designation and represents a continuation of Cepheid's established role as a primary supplier of molecular diagnostic testing...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $202,883.65 by the Veterans Integrated Service Network (VISN) 6 on April 1, 2025, for Cepheid molecular diagnostic testing system reagents, assays, and lease services. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, operates under a larger single-award Indefinite Delivery Contract (IDC) between Cepheid and VISN 6 valued at $32.8 million and extending...
- Cepheid Inc. has been awarded a delivery order valued at $333,567.56 by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21), with a firm fixed-price structure and ultimate completion date of March 15, 2026. This delivery order represents a continuation of the agency's procurement of molecular diagnostic solutions from Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems and reagents. The award carries no set-aside...
- Cepheid Inc. has been awarded a delivery order valued at $247,262.22 by Veterans Integrated Service Network 9 (VISN 9), a component of the Department of Veterans Affairs, for Cepheid medical equipment reagents to support patient testing. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2026, carries no set-aside designation and represents a continuation of the company's established role as a primary supplier of molecular diagnostic solutions to the VA...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $2.27 million firm fixed-price purchase order by the Department of Veterans Affairs through Veterans Integrated Service Network 20 for the lease and purchase of a molecular diagnostic testing system along with instrument-specific assays. The contract, awarded on August 1, 2022, with an ultimate completion date of July 31, 2027, carries no set-aside designation and represents part of the VA's broader reliance on Cepheid as a...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order by the Department of Veterans Affairs (Veterans Integrated Service Network 21) on October 1, 2024, for GeneXpert test kits valued at $505,664.35. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, will be performed in San Francisco, California. No set-aside designation was used for this procurement. This award represents a...
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, received a $42,410.16 firm fixed-price purchase order from Veterans Integrated Service Network 5 (VISN 5) for PCR testing services, with a completion date of September 30, 2026. The award, issued on April 5, 2026, carries no set-aside designation and represents a direct procurement for diagnostic testing capabilities to support VA healthcare operations. This purchase order is consistent with Cepheid's established role as a primary federal supplier of molecular diagnostic solutions, particularly through its GeneXpert diagnostic platform and associated testing reagents. This procurement aligns with Cepheid's broader relationship with the Department of Veterans Affairs, which includes two significant Indefinite Delivery Contracts valued at $6.7 million and $32.8 million with VISN 17 and VISN 6, respectively. The company's extensive portfolio of federal contracts across multiple Veterans Integrated Service Networks, the Indian Health Service, Defense Health Agency, and other federal agencies demonstrates substantial capability in supplying diagnostic equipment, reagents, test kits, and maintenance services. The current purchase order represents ongoing demand-driven procurement to support the VA's clinical laboratory operations and infectious disease testing requirements across its healthcare network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.4k | 2/6/26 |